Literature DB >> 8102569

A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus.

C J Watson1, L Gaunt, G Evans, K Patel, R Harris, T Strachan.   

Abstract

RFLP typing of members of a neurofibromatosis type 2 (NF2) family suggested that affected individuals were hemizygous at the neurofilament heavy chain (NEFH) locus, possibly as a result of a disease-associated deletion. Conventional karyotyping revealed no evidence for a deletion and all or a majority of the affected family members were heterozygous for closely linked markers which mapped proximal to the NEFH locus (D22S1 and D22S56) and for the distal marker D22S32. FISH analysis confirmed a disease-associated germinal deletion on 22q which encompassed the NEFH locus, which is known to be very closely linked to NF2, but did not extend as far as the proximal Ewing sarcoma region or the distal leukaemia factor (LIF) locus. PFGE analysis with a LIF cosmid subclone identified patient-specific NotI and MluI fragments and suggested that the deletion is about 700 kb in length. Although this large deletion could be expected to eliminate a considerable fraction, and possibly all of the NF2 gene, the resulting phenotype is the mild, so-called Gardner subtype of NF2. The deletion should provide a useful mapping resource for characterising the chromosomal region containing the NF2 locus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102569     DOI: 10.1093/hmg/2.6.701

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  10 in total

Review 1.  Neurofibromatosis type 2.

Authors:  D G Evans; M Sainio; M E Baser
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

2.  Chromosome 22q12.1 microdeletions: confirmation of the MN1 gene as a candidate gene for cleft palate.

Authors:  Jeroen Breckpot; Britt-Marie Anderlid; Yasemin Alanay; Moira Blyth; Afane Brahimi; Bénédicte Duban-Bedu; Odile Gozé; Helen Firth; Mustafa Cengiz Yakicier; Greet Hens; Maissa Rayyan; Eric Legius; Joris Robert Vermeesch; Koen Devriendt
Journal:  Eur J Hum Genet       Date:  2015-05-06       Impact factor: 4.246

3.  Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.

Authors:  D M Parry; M M MacCollin; M I Kaiser-Kupfer; K Pulaski; H S Nicholson; M Bolesta; R Eldridge; J F Gusella
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

4.  A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals.

Authors:  D Bourn; S A Carter; D G Evans; J Goodship; H Coakham; T Strachan
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

5.  Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.

Authors:  D G Evans; L Trueman; A Wallace; S Collins; T Strachan
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

6.  A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.

Authors:  L Kluwe; V F Mautner
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

7.  Diagnostic issues in a family with late onset type 2 neurofibromatosis.

Authors:  D G Evans; D Bourn; A Wallace; R T Ramsden; J D Mitchell; T Strachan
Journal:  J Med Genet       Date:  1995-06       Impact factor: 6.318

Review 8.  Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature.

Authors:  Tom B Davidson; Pedro A Sanchez-Lara; Linda M Randolph; Mark D Krieger; Shi-Qi Wu; Ashok Panigrahy; Hiroyuki Shimada; Anat Erdreich-Epstein
Journal:  BMC Med Genet       Date:  2012-03-22       Impact factor: 2.103

9.  A large germline deletion of the MEN1 gene in a family with multiple endocrine neoplasia type 1.

Authors:  M Kishi; T Tsukada; S Shimizu; H Futami; Y Ito; M Kanbe; T Obara; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1998-01

10.  Characterization of 22q12 Microdeletions Causing Position Effect in Rare NF2 Patients with Complex Phenotypes.

Authors:  Viviana Tritto; Marica Eoli; Rosina Paterra; Serena Redaelli; Marco Moscatelli; Francesco Rusconi; Paola Riva
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.